Charlotte, North Carolina
Medicare GLP-1 Bridge in Charlotte, NC
Medicare started a program on July 1, 2026 that lets eligible people with Part D get certain weight-management GLP-1 medications for $50 a month. Here is who qualifies, which drugs are covered, and what our clinic does to get you through it.
Prefer to call? (980) 306-2060
Board-Certified Internal Medicine • Medicare Accepted • In-Person Charlotte & Virtual NC/SC
What the Medicare GLP-1 Bridge Is
Medicare Part D has not generally covered medications used for weight loss alone. The Medicare GLP-1 Bridge is a temporary program that changes that for people who qualify.
It runs from July 1, 2026 through December 31, 2027. During that window, eligible Part D beneficiaries pay $50 per month for a covered GLP-1, no matter their income.
Your Part D plan does not have to opt in for you to use it. What matters is whether you meet the eligibility rules and whether Medicare approves your request.
Which Medications Are Covered
- Foundayo® (orforglipron), the tablet
- Wegovy® (semaglutide), injection or tablet
- Zepbound® (tirzepatide), KwikPen® only
The Zepbound detail matters. The Bridge covers the KwikPen only. Zepbound single-dose pens and vials are not covered under this program. If you are already on a single-dose pen or a vial, Dr. Okoye will discuss switching you to the KwikPen before your request goes in.
Read more about each option on our pages for Wegovy, Zepbound, and Foundayo.
Who Qualifies
Medicare set four requirements. You need to meet all four.
- You have Medicare Part D coverage, either a standalone drug plan or drug coverage built into your Medicare plan. Some special plan types, such as private fee-for-service plans, are not eligible.
- You are not already getting a GLP-1 through your Medicare drug plan.
- You do not have a diagnosis of type 2 diabetes, moderate to severe sleep apnea, or fatty liver disease. Those diagnoses route you to a different coverage pathway, not to this one.
- You are 18 or older and meet one of these BMI thresholds:
- BMI of 35 or higher, or
- BMI of 30 or higher with heart failure, uncontrolled high blood pressure, or chronic kidney disease at stage 3a or beyond, or
- BMI of 27 or higher with prediabetes or a history of a cardiovascular event.
You can check your number with our adult BMI calculator before your visit. We confirm it in the office and document it, because Medicare requires the BMI recorded at the time treatment starts.
If point 3 surprised you
It surprises a lot of patients. Having type 2 diabetes, moderate to severe sleep apnea, or fatty liver disease does not mean you cannot get a GLP-1. It means the Bridge is not your route. Those conditions often open coverage through your regular Part D benefit instead, because the medication is being used to treat the condition rather than for weight alone. Dr. Okoye works out which pathway fits you at your visit.
What $50 a Month Actually Means
The $50 is your cost for a one-month supply of the medication, regardless of income. Three things about it are worth knowing before you plan around it:
- It sits outside the normal Part D payment flow, so your Part D deductible does not apply.
- It does not count toward your out-of-pocket maximum or your true out-of-pocket total.
- Extra Help and other low-income subsidies do not reduce it. Everyone in the program pays the same $50.
The $50 covers the medication only. Your office visits, labs, and body composition testing are billed to your medical benefit separately. See our pricing and self-pay options page for visit costs.
How It Works at Our Clinic
- You come in for a medical evaluation. Dr. Okoye reviews your full health history, your medications, and your other conditions, and we run Tanita body composition analysis in the office.
- We confirm and document your BMI along with any qualifying condition, because Medicare requires that documentation at the point treatment starts.
- Dr. Okoye decides whether a GLP-1 is right for you and which one. Eligibility for the program and clinical appropriateness are two separate questions.
- Our team submits your request to Medicare. Approval has to come through before your pharmacy can dispense.
- You bring your Medicare ID to the pharmacy. Once Medicare has approved, the pharmacy fills at the $50 copay.
- You come back for follow-up. We adjust your dose, repeat labs when they are due, and manage the rest of your health as your weight changes.
Medicare makes the final decision on your request. Meeting the criteria on this page does not by itself guarantee approval, and it does not guarantee that a given medication will be available at your pharmacy. Our team prepares and submits the documentation and follows up on it.
If You Do Not Qualify
There is more than one way to get treated. Depending on your situation:
- If you have type 2 diabetes, sleep apnea, or fatty liver disease, your regular Part D benefit may be the route. Read our insurance and coverage guide.
- If you are already on a GLP-1 through your plan, you are already in coverage and the Bridge does not apply.
- Manufacturer savings programs can reduce cost for some patients.
- Self-pay is available, and we tell you the numbers before treatment starts.
If you also have TRICARE, read our TRICARE weight loss care guide, because TRICARE has separate rules. If you have Medicaid, see NC Medicaid or SC Medicaid weight loss coverage.
Staying on Treatment After the Program Ends
The Bridge is scheduled to end on December 31, 2027. Weight regain after stopping a GLP-1 is common, because the condition being treated does not go away. Dr. Okoye plans for that from the start rather than at the end, and builds a maintenance approach with you. Read more about GLP-1 weight maintenance.
Frequently Asked Questions
Does being eligible mean my medication is automatically covered?
No.
Medical visits and prescription medications are separate insurance benefits, and the Bridge is a separate pathway again. Your request goes to Medicare for approval before your pharmacy can dispense. Medicare is the final authority on coverage and on what you pay.
When did the program start and when does it end?
It started July 1, 2026 and is scheduled to run through December 31, 2027.
Do I need a specific Part D plan?
You need Part D drug coverage, either standalone or built into your Medicare plan. Some special plan types, such as private fee-for-service plans, are not eligible. Your plan does not have to opt in to the program for you to use it.
I have type 2 diabetes. Can I use the Bridge?
No. A type 2 diabetes diagnosis makes you ineligible for this program. That is not the same as being unable to get treated. Coverage through your regular Part D benefit is often the better route in that case, and Dr. Okoye will work it out with you.
Does Extra Help lower the $50?
No. The $50 is the same for everyone in the program regardless of income, and low-income subsidies do not apply to it.
Which Zepbound form is covered?
The KwikPen® only. Single-dose pens and vials are not covered under the Bridge.
Do you prescribe compounded GLP-1 medications?
No. We prescribe brand-name, FDA-approved medication filled through licensed retail pharmacies.
Can I do this virtually?
Initial and follow-up visits are available in person or virtually. Tanita body composition analysis requires an in-person visit at our Charlotte office. We see patients from across the Charlotte region and virtually throughout North Carolina and South Carolina. See the communities we serve.
Where is the clinic?
1220 Eastway Drive, Suite C, Charlotte, NC 28205. Monday to Friday, 8:30 AM to 4:30 PM.
Find Out Where You Stand
Bring your Medicare card and your medication list. Dr. Okoye will tell you which pathway fits your health and your coverage.
Or call (980) 306-2060
Charlotte Weight Loss and Wellness Clinic, PLLC
1220 Eastway Drive, Suite C, Charlotte, NC 28205
Care directed by Dr. Joseph Okoye, MD, FACP
Program Information Note
Program information reviewed September 7, 2026.
Program rules, covered medications, and eligibility criteria described here reflect Centers for Medicare & Medicaid Services and Medicare.gov information available on the review date. Medicare can change them. Your own eligibility and your cost are determined by Medicare, not by our clinic. We confirm current requirements when care or medication is being arranged.
Wegovy® is a registered trademark of Novo Nordisk. Zepbound® and KwikPen® are registered trademarks of Eli Lilly and Company. Foundayo® is a registered trademark of Eli Lilly and Company. Trademarks belong to their respective owners.
Treatment recommendations are individualized and based on medical evaluation, health history, medication safety considerations, insurance coverage, medication availability, and clinician judgment.